Fillers
4 min readHow Much Hyaluronidase Should a Clinic Stock?
Educational reading for licensed practitioners — not clinical or injection guidance.
Ask an experienced injector what the single most important item in their clinic is, and many will not name a filler at all — they will name hyaluronidase. It is the reversal agent for hyaluronic acid and the cornerstone of emergency management for vascular occlusion. Yet clinics routinely under-stock it, and "we keep one vial in the fridge" is not a plan. This is general guidance on preparedness, not clinical dosing advice.
Why One Vial Is Not Enough
The mistake is imagining hyaluronidase as a spare part you rarely touch, like a fire extinguisher you hope never to use. The problem is the way an emergency actually unfolds. Managing a suspected vascular occlusion is not a single injection — established protocols involve flooding the affected vascular territory with a high dose, reassessing, and re-dosing repeatedly until perfusion returns. A serious event can consume far more enzyme than a novice expects, and it can do so within a very short window.
That has a blunt implication: the amount you need on hand is driven by the worst foreseeable emergency, not by your average day of elective work. A clinic that treats high-risk areas — nose, glabella, tear trough — should stock accordingly, and should hold enough to sustain a protocolised, escalating response rather than run out mid-emergency. Specific dosing sits within accredited complication-management training and current guidance, and must not be improvised from an article.
The Non-Negotiable Rule
The principle underneath all of this is straightforward: no HA filler should be injected unless in-date hyaluronidase is immediately accessible in the same room. An emergency kit stored off-site, in a locked cupboard nobody can open quickly, or expired, is functionally no kit at all. Time is tissue — the value of the enzyme collapses if it is not to hand the moment it is needed.
Building a Compliant Occlusion Kit
Hyaluronidase is only one element. A properly assembled occlusion kit brings together everything the protocol requires so that nothing has to be hunted for under pressure:
- Hyaluronidase — enough for a full, repeated-dose emergency response, in date, with a stock-rotation system
- Sterile saline for reconstitution and dilution
- Syringes and drawing-up needles — a supply of 1cc syringes and appropriate needles dedicated to the kit, not borrowed from the treatment tray
- A written emergency protocol displayed where staff can follow it step by step
- Aspirin and the other adjuncts specified by your training and guidance
- A clear escalation pathway, including immediate referral for any suspected visual compromise
- Documentation forms to record the event and response
The kit should be checked on a schedule, restocked immediately after any use, and known to every clinician who injects.
Storage, Shelf Life and Rotation
Hyaluronidase products have specific storage requirements and expiry dates, and once reconstituted they are used promptly rather than stored. The practical discipline is stock rotation: track expiry dates, use older stock first for any elective dissolving work, and never let the emergency allocation lapse. A vial that expired last month provides false reassurance, which is worse than none. Follow the manufacturer's storage and handling instructions for the specific product you hold.
Elective Versus Emergency Stock
Many clinics also use hyaluronidase electively — to dissolve migrated, overfilled or unwanted HA. It is sensible to think of these as two separate pools. Elective dissolving should never draw down the reserve you rely on for an emergency; if a busy dissolving week leaves your emergency allocation depleted, you are exposed. Keep the emergency stock ring-fenced and replenish it as a priority.
Preparedness Is a Team Habit
A kit is only as good as the people around it. In a real emergency the injector may need a second pair of hands, so every clinician — and ideally the wider team — should know where the occlusion kit lives, how to reconstitute the enzyme, and what their role is while the lead practitioner manages the patient. Rehearsing the sequence, the way clinics rehearse other emergencies, turns a panicked scramble into a practised response. Reviewing the kit and the protocol at regular intervals keeps that readiness from quietly decaying between the rare occasions it is actually needed. Stocking the enzyme is the beginning of preparedness, not the whole of it.
The Takeaway
Stock hyaluronidase for the worst foreseeable emergency, not the average day; keep it in date, in the room, and ring-fenced from elective use; and build it into a complete occlusion kit with saline, syringes, a written protocol and an escalation pathway. Preparedness, not the vial itself, is what protects patients. Pair your genuine dermal fillers range with an emergency kit that is genuinely ready — and complete accredited complication training to learn the dosing this article deliberately does not give.